Use of functional protein pathway activation mapping in glioblastoma samples to differentiate long-term from short-term survivors along with pathway-driven molecular subgroups.

Abstract

2051 Background: Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults. It is highly lethal, with a median survival time of 9 to 18 months. New prognostic biomarkers are cr...